The reset and transdifferentiation of bone marrow stromal cells and developmental research for organ regeneration

骨髓基质细胞的重置、转分化及器官再生的发育研究

基本信息

  • 批准号:
    15590166
  • 负责人:
  • 金额:
    $ 2.37万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2004
  • 项目状态:
    已结题

项目摘要

Bone marrow stromal cells (MSCs) have the capability under specific conditions to differentiate into other cell types. In this study, we demonstrate a highly efficient and specific induction of cells with neuronal, Schwann cells and skeletal muscle characteristics.Neurons : MSCs were transfected with Notch intracellular domain(NICD) followed by cytokine treament. (bFGF+CNTF+forskolin). Induced neuronal cells expression neuronal markers, and showed voltage-gated fast sodium and action potentials. Glial markers could not be detected. Further treatment of the induced neuronal cells with GDNF increased the proportion of tyrosine hydroxylase (TH)-positive cells. Transplantation of these GDNF-treated cells showed improvement in apomorphine-induced rotational behavior, following intrastriatal implantation in a 6-hydroxy dopamine rat model of Parkinson's disease.Schwann cells : Cells were treated with beta-mercaptoethanol and retinoic acid, followed by treatment with cytokines of bFGF, FSK, PD … More GF and neuregulin. MSCs changed their morphology after treatment with expression of Schwann cell markers of p75, GFAP, S-100 and P0. Transplantation of induced cells improved the function of spinal cord contusion injury model rats.Skeletal muscle cells : MSCs were treated with cytokines (FSK+bFGF+PGDF+neuregulin) followed by NICD transfection. Induced cells expressed MyoD, Myogenin and other skeletal muscle markers and Pax7, c-MetR satellite cell markers, and formed multinuclear skeletal muscle cells. After intravenous transplantation of induced cell, muscle regeneration and integration of induced cells could be observed in mdx-mice (muscle dystrophy model mice).MSCs have a great potential as therapeutic agents against neurological diseases since they can be readily obtained through a well-established clinical procedure and are easy to isolate and expand for autotransplantation with no risk of rejection. This study shows that a population of neuronal cells can be specifically generated from MSCs and that induced cells may allow for a neuroreconstructive approach. Less
骨髓基质细胞(MSCs)在特定条件下具有分化为其他细胞类型的能力。在本研究中,我们证明了一种高效和特异性的诱导细胞具有神经元,雪旺细胞和骨骼肌的特性。神经元:MSC转染Notch细胞内结构域(NICD),然后用细胞因子处理。(bFGF+CNTF+毛喉素)。诱导的神经元细胞表达神经元标记物,并显示电压门控快钠和动作电位。未检测到神经胶质标志物。进一步用GDNF处理诱导的神经元细胞增加酪氨酸羟化酶(TH)阳性细胞的比例。将这些GDNF处理的细胞移植到帕金森病的6-羟基多巴胺大鼠模型的纹状体内后,显示出阿扑吗啡诱导的旋转行为的改善。 ...更多信息 GF和神经调节蛋白。在表达雪旺细胞标志物p75、GFAP、S-100和P0的处理后,MSC改变其形态。骨骼肌细胞:细胞因子(FSK+bFGF+PGDF+neuregulin)处理MSCs后,NICD转染。诱导细胞表达MyoD、Myogenin等骨骼肌标志物和Pax 7、c-MetR卫星细胞标志物,形成多核骨骼肌细胞。静脉内移植诱导细胞后,在mdx小鼠(肌肉营养不良模型小鼠)中可以观察到肌肉再生和诱导细胞的整合。MSC作为神经系统疾病的治疗剂具有很大的潜力,因为它们可以通过完善的临床程序容易地获得,并且易于分离和扩增用于自体移植,没有排斥反应的风险。这项研究表明,一个群体的神经元细胞可以特异性地产生从骨髓间充质干细胞和诱导细胞可能允许神经重建的方法。少

项目成果

期刊论文数量(72)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ishikawa H, Takano M, Matsumoto N, Sawada H, Ide C, Mimura O, Dezawa M: "The effect of GDNF gene transfer into axotomized retinal ganglion cells using in vivo electroporation with contact type electrode Gene"Gene Therapy. (in press).
Ishikawa H、Takano M、Matsumoto N、Sawada H、Ide C、Mimura O、Dezawa M:“使用接触型电极体内电穿孔将 GDNF 基因转移到轴突视网膜神经节细胞中的效果”基因治疗。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Implantation of neural stem cells via cerebrospinal fluid into the injured root
通过脑脊液将神经干细胞植入受伤的根部
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ohta M;Suzuki Y;Noda T;Kataoka K;Chou H;Ishikawa N;Kitada M;Matsumoto N;Dezawa M;Suzuki S;Ide C
  • 通讯作者:
    Ide C
Novel heparin/alginate gel combined with basic fibroblast growth factor promotes nerve regeneration in rat sciatic nerve
Ohumra M, Ogawa T, Ono M, Dezawa M, Hosaka M, Kubota Y, Sawada H: "Increment of Murine Spermatogonial Cell Number by Gonadotropin-Releasing Hormone Analogue Is Independent of Stem Cell Factor - c-kit signal"Biol Reprod. 68. 2304-2313 (2003)
Ohumra M、Okawa T、Ono M、Dezawa M、Hosaka M、Kubota Y、Sawada H:“促性腺激素释放激素类似物增加小鼠精原细胞数量独立于干细胞因子 - c-kit 信号”Biol Reprod。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation
  • DOI:
    10.1172/jci200420935
  • 发表时间:
    2004-06-01
  • 期刊:
  • 影响因子:
    15.9
  • 作者:
    Dezawa, M;Kanno, H;Ide, C
  • 通讯作者:
    Ide, C
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DEZAWA Mari其他文献

DEZAWA Mari的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DEZAWA Mari', 18)}}的其他基金

Search for innovative organ transplantation without the need for relatives or HLA matching
寻找创新的器官移植,无需亲属或 HLA 匹配
  • 批准号:
    19K22648
  • 财政年份:
    2019
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Suggested common mechanism underlying between human Muse cells and planarian neoblasts
人类 Muse 细胞和涡虫新生细胞之间潜在的共同机制
  • 批准号:
    25670135
  • 财政年份:
    2013
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Possibility of transplantation of human skin-derived pluripotent stem cells into the bone marrow
将人类皮肤来源的多能干细胞移植到骨髓中的可能性
  • 批准号:
    23659145
  • 财政年份:
    2011
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Characterization of Muse cells, non-tumorigenic intrinsic pluripotent stem cells, and their application to regenerative medicine.
Muse 细胞、非致瘤性内在多能干细胞的表征及其在再生医学中的应用。
  • 批准号:
    23390060
  • 财政年份:
    2011
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The mechanism of transdifferentiation in bone marrow stromal cells
骨髓基质细胞转分化机制
  • 批准号:
    19390074
  • 财政年份:
    2007
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Development and Translation Mass Spectrometry Methods to Determine BioMarkers for Parkinson's Disease and Comorbidities
确定帕金森病和合并症生物标志物的质谱方法的开发和转化
  • 批准号:
    2907463
  • 财政年份:
    2024
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Studentship
Development of a predictive biomarker for Parkinson's disease
帕金森病预测生物标志物的开发
  • 批准号:
    MR/Y019415/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Research Grant
Promoting Parkinson's disease trial participation in rural and coastal communities
促进农村和沿海社区参与帕金森病试验
  • 批准号:
    2898794
  • 财政年份:
    2024
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Studentship
Neurophysiological mechanism underlying freezing of gait in Parkinson's disease: transcutaneous spinal cord stimulation for gait disturbance
帕金森病步态冻结的神经生理机制:经皮脊髓刺激治疗步态障碍
  • 批准号:
    23K10409
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Inhibition of cell-to-cell propagation of alpha-synuclein aggregation by glial cells and its involvement in neuropathology in Parkinson's disease.
神经胶质细胞抑制α-突触核蛋白聚集的细胞间传播及其参与帕金森病的神经病理学。
  • 批准号:
    23K06928
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Propagation of a-synuclein in Parkinson's disease progress
α-突触核蛋白在帕金森病进展中的传播
  • 批准号:
    22KJ2095
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
The Diagnostic and Prognostic Utility of Eye Tracking in Parkinson's Disease and Related Disorders
眼动追踪在帕金森病及相关疾病中的诊断和预后效用
  • 批准号:
    479285
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Operating Grants
Drug-microbiome-host interactions in Parkinson's disease
帕金森病的药物-微生物组-宿主相互作用
  • 批准号:
    2881438
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Studentship
MICA: How does the pedunculopone nucleus influence treatment responses in Parkinson's disease, and can it be targeted for new treatment strategies
MICA:脚核如何影响帕金森病的治疗反应,是否可以作为新治疗策略的目标
  • 批准号:
    MR/X005267/1
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Research Grant
Ordering the disordered in Parkinson's disease to derive peptide inhibitors of alpha-synuclein toxicity
命令帕金森病患者衍生出α-突触核蛋白毒性的肽抑制剂
  • 批准号:
    2884235
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了